Acute Exercise and NK Cell Regulation in Tissue and Circulation After IL-6R Blockade

计划入组 30 人 · 首次发布于 2020 年 11 月 4 日

A Study of Anti-IL-6R mAb Injection in Patients With iMCD

计划入组 25 人 · 首次发布于 2022 年 4 月 26 日

Clinical Study of Single Dose IL-6R mAb Injection in RA Patients

计划入组 40 人 · 首次发布于 2022 年 2 月 9 日

Anti IL-6R mAb

ACE2-Fc-anti-IL-6R scfv fusion protein

Recombinant humanized anti-IL-6R antibody(Livzon Pharmaceutical Group, Inc.)

Simcha Il 18, Inc.

United States

Alliance Foundation Trials, LLC

United States

UNIVERSITA' DEGLI STUDI DI ROMA LA SAPIENZA

Italy

Tiziana Life Sciences Advances IL-6 Receptor Antibody TZLS-501 Following Novartis' $1.4B Tourmaline Acquisition

Sarilumab Demonstrates Significant Quality of Life Improvements in Polymyalgia Rheumatica Phase 3 Trial

Eluminex Biosciences Reports Positive Phase 1b Results for Novel Pentavalent Antibody EB-105 in Diabetic Macular Edema